The Immunotherapeutic Role of Bacterial Lysates in a Mouse Model of Asthma

Lung

Volumn 195, Issue 5, 2017, Pages 563-569

  Liu, Chentao ^a   Huang, Rong ^a   Yao, Rujie ^a   Yang, Aimei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Asthma; Bacterial lysates (OM 85); Exacerbation; Immunotherapy; MICE

Indexed keywords

ALUMINUM HYDROXIDE; BACTERIUM LYSATE; BUDESONIDE; GAMMA INTERFERON; INTERLEUKIN 4; OVALBUMIN; BRONCHO-VAXOM; CELL EXTRACT; CYTOKINE; IMMUNOLOGICAL ADJUVANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELLULAR IMMUNITY; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HISTOLOGY; IMMUNOMODULATION; IMMUNOTHERAPY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LUNG PARENCHYMA; LYMPHOCYTE; MONOCYTE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; TH1 CELL; TH2 CELL; ANIMAL; BRONCHUS; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; LUNG; MUCUS; ORAL DRUG ADMINISTRATION; PATHOLOGY;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ASTHMA; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; CELL EXTRACTS; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; FEMALE; IMMUNOTHERAPY; LUNG; MICE; MUCUS; NEUTROPHILS; TH1 CELLS; TH2 CELLS;

EID: 85018745915     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-017-0003-8     Document Type: Article

References (36)

1. Kusel MM, de Klerk NH, Kebadze T et al (2007) Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 119(5):1105–1110
2. Sly PD, Kusel M, Holt PG (2010) Do early-life viral infections cause asthma? J Allergy Clin Immunol 125(6):1202–1205
3. Jackson DJ, Gangnon RE, Evans MD et al (2008) Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 178(7):667–672
4. Murray CS, Poletti G, Kebadze T et al (2006) Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 61(5):376–382
5. Heymann PW, Carper HT, Murphy DD et al (2004) Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol 114(2):239–247
6. Inoue Y, Shimojo N (2013) Epidemiology of virus-induced wheezing/asthma in children. Front Microbiol 16(4):391
7. Jackson DJ, Lemanske RF Jr (2010) The role of respiratory virus infections in childhood asthma inception. Immunol Allergy Clin N Am 30(4):513–522
8. Linder JE, Kraft DC, Mohamed Y et al (2013) Human rhinovirus C: age, season, and lower respiratory illness over the past 3 decades. J Allergy Clin Immunol 131(1):69–77
9. Forno E, Celedón JC (2012) Predicting asthma exacerbations in children. Curr Opin Pulm Med 18(1):63–69
10. Ahanchian H, Jones CM, Chen YS et al (2012) Respiratory viral infections in children with asthma: do they matter and can we prevent them? BMC Pediatr 13(12):147
11. Wu P, Hartert TV (2011) Evidence for a causal relationship between respiratory syncytial virus infection and asthma. Expert Rev Anti Infect Ther 9(9):731–745
12. Gern JE (2009) Rhinovirus and the initiation of asthma. Curr Opin Allergy Clin Immunol 9(1):73–78
13. De Benedetto F, Sevieri G (2013) Prevention of respiratory tract infections with bacterial lysate OM-85 bronchomunal in children and adults: a state of the art. Multidiscip Respir Med 8(1):33
14. Ahrens B, Quarcoo D, Buhner S et al (2011) Oral administration of bacterial lysates attenuates experimental food allergy. Int Arch Allergy Immunol 156(2):196–204
15. Lau S (2013) Oral application of bacterial lysate in infancy diminishes the prevalence of atopic dermatitis in children at risk for atopy. Benef Microbes 25:1–3
16. Lu Y, Li Y, Xu L et al (2015) Bacterial lysate increases the percentage of natural killer T cells in peripheral blood and alleviates asthma in children. Pharmacology 95(3–4):139–144
17. Vissers JL, van Esch BC, Hofman GA et al (2004) Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model. J Allergy Clin Immunol 113(6):1204–1210
18. Ford JG, Rennick D, Donaldson DD et al (2001) Il-13 and IFN-gamma: interactions in lung inflammation. J Immunol 167(3):1769–1777
19. Sagar S, Verheijden KA, Georgiou NA et al (2013) Differential regulation of inflammation and immunity in mild and severe experimental asthma. Mediat Inflamm 2013:808470
20. Holgate ST (2012) Innate and adaptive immune responses in asthma. Nat Med 18(5):673–683
21. Bogaert P, Tournoy KG, Naessens T et al (2009) Where asthma and hypersensitivity pneumonitis meet and differ: noneosinophilic severe asthma. Am J Pathol 174(1):3–13
22. Fahy JV (2009) Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc Am Thorac Soc 6(3):256–259
23. Antoniu SA (2010) MEDI-528, an anti-IL-9 humanized antibody for the treatment of asthma. Curr Opin Mol Ther 12:233–239
24. Gauvreau GM, Boulet LP, Cockcroft DW et al (2011) Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. Am J Respir Crit Care Med 183:1007–1014
25. Mullane K (2011) Asthma translational medicine: report card. Biochem Pharmacol 82:567–585
26. Okayama Y (2013) Cellular and humoral immunity of virus-induced asthma. Front Microbiol 27(4):252
27. Jackson DJ, Lemanske RF Jr (2010) The role of respiratory virus infections in childhood asthma inception. Immunol Allergy Clin N Am 30(4):513–522
28. Dulek DE, Peebles RS Jr (2011) Viruses and asthma. Biochim Biophys Acta 1810(11):1080–1090
29. Podleski WK (1985) Immunomodulation of allergic autocytotoxicity in bronchial asthma by a bacterial lysate–Broncho-Vaxom. Int J Immunopharmacol 7(5):713–718
30. Weinberger M (2010) Can we prevent exacerbations of asthma caused by common cold viruses? J Allergy Clin Immunol. 126(4):770–771
31. Schaad UB (2010) OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J Pediatr 6(1):5–12
32. Razi CH, Harmancı K, Abacı A et al (2010) The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol 126(4):763–769
33. Rozy A, Chorostowska-Wynimko J (2008) Bacterial immunostimulants—mechanism of action and clinical application in respiratory diseases. Pneumonol Alergol Pol 76(5):353–359
34. Strickland DH, Judd S, Thomas JA et al (2011) Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma control. Mucosal Immunol 4:43–52
35. Navarro S, Cossalter G, Chiavaroli C et al (2011) The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways. Mucosal Immunol 4:53–65
36. Fu R, Li J, Zhong H, Yu D et al (2014) Broncho-Vaxom attenuates allergic airway inflammation by restoring GSK3β-related T regulatory cell insufficiency. PLoS One 9(3):e92912